Maine Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 13 (72% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 2,482
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 8.08%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 235
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 4.05%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 86.18% 90.64%
White, Hispanic/Latino Patients 2.14% 2.13%
Black/African American, Non-Hispanic/Latino Patients 3.06% 0.00%
Black/African American, Hispanic/Latino Patients 0.00% 0.00%
Asian Patients3 0.32% 0.00%
American Indian/Alaska Native Patients3 1.17% 1.70%
Native Hawaiian/Other Pacific Islander Patients3 0.00% 0.00%
Patients with More than one race3 0.73% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.16% 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.81% 0.85%
Unreported/Refused to Report Race and Ethnicity 5.44% 4.68%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 261
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 18.64%
COVID-19 Immunization Series Completed 330
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 12.59%
COVID-19 Immunization Series Additional 125
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 0.00%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 73.56% 75.76% 94.40%
White, Hispanic/Latino Patients 1.53% 0.30% 0.00%
Black/African American, Non-Hispanic/Latino Patients 11.49% 8.18% 0.00%
Black/African American, Hispanic/Latino Patients 0.00% 0.00% 0.00%
Asian Patients3 1.53% 0.30% 0.00%
American Indian/Alaska Native Patients3 1.53% 1.21% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.00% 0.30% 0.00%
Patients with More than one race3 0.77% 0.61% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.00% 0.00% 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.15% 4.24% 0.80%
Unreported/Refused to Report Race and Ethnicity 8.43% 9.09% 4.80%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 23.08%
1 to 24 Hours 53.85%
More Than 24 Hours 23.08%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 30.77%
Vaccine confidence 53.85%
Vaccine storage capacity 7.69%
Vaccine supply 7.69%
Other 7.69%
None 23.08%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 30.77%
Average Percent of Health Center Visits Conducted Virtually 19.23%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 38.46%
Number of Mobile Van Sites 0
Number of Pop-up Clinics 11
Number of School-Based Vaccination Sites 5

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 53.85%
None 46.15%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 15.38%
Patient awareness/education 15.38%
Staffing capacity 23.08%
Therapy administration/onsite logistics 23.08%
Other 7.69%
None 53.85%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021